Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-12-04

Clinical Trial Update: Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & Morphine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ibuprofen with morphine or diamorphine for acute pain in sickle cell disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diamorphine (diacetylmorphine)
  • Ibuprofen (IBUPROFEN)
  • Morphine (morphine)

Snippet

Sponsor: London North West Healthcare NHS Trust | Conditions: Sickle Cell Disease | Phase 4 | Status: TERMINATED